Veeva Systems' trading volume on February 11th was $755 million, a 103.08% increase compared to the previous trading day.

2026-02-21 14:38:20

On February 11, 2026, healthcare technology company Veeva Systems (VEEV) had a trading volume of $755 million, ranking 198th among U.S. stocks that day, with a 103.08% increase in trading volume compared to the previous day. The trading volume was 4.2828 million shares.

Veeva Systems (VEEV) declined 5.32% on February 11, 2026, closing at $177.04. The stock has fallen 7.16% over the past five trading days, down 13.18% for February, and is down 20.69% year-to-date. Over the past 52 weeks, it has decreased by 24.45%.

If the company has been listed for less than 52 weeks, the 52-week change is calculated from the listing date to now (this also applies to listings of less than 1 month or fewer than 5 trading days).

Veeva Systems (VEEV)	Trading Volume / USD	Change in Trading Volume from Yesterday	Volume
February 11, 2026	$755 million	103.08%	4.2828 million
February 10, 2026	$372 million	-7.02%	1.9769 million
February 9, 2026	$400 million	-22.74%	2.1792 million
February 6, 2026	$518 million	8.54%	2.8462 million
February 5, 2026	$477 million	-36.05%	2.5752 million

Veeva Systems released its fiscal third quarter (cumulative) report for 2026 on November 21, 2025. From February 1, 2025, to October 31, 2025, revenue was $2.359 billion, a year-over-year increase of 16.47%. Net profit was $665 million, up 28.19% year-over-year.

Veeva Systems Inc. is a leading global provider of cloud-based software solutions for the life sciences industry. Its solutions enable pharmaceutical and other life sciences companies to modernize their cloud architecture and benefit from mobile applications for their most critical business functions without compromising industry-specific features or regulatory compliance. The company was founded in Delaware in January 2007 and renamed Veeva Systems Holdings in April 2009 from Verticals onDemand Holdings.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.